Form 4: IGM Biosciences Director Elizabeth Thompson Acquires Shares as Part of Compensation

Director Elizabeth Thompson acquired 1,452 shares of IGM Biosciences common stock on September 30, 2024, as part of a quarterly retainer.

Summary

• On September 30, 2024, Elizabeth H.Z. Thompson, a director of IGM Biosciences, acquired 1,452 shares of common stock.
• The acquisition was made through fully vested restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of IGM Biosciences common stock.
• The shares were acquired as partial payment of a quarterly retainer, according to the Issuer's Outside Director Compensation Policy.
• Following the transaction, Thompson directly owns 4,356 shares of IGM Biosciences common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but it's part of a pre-defined compensation plan, so it's not a major surprise.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of RSUs as part of director compensation aligns the director's interests with those of shareholders.

Industry Context

Director share acquisitions are common and can be seen as a positive signal, indicating confidence in the company's future performance. The use of RSUs is a typical method of compensating board members.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders, as it signals confidence from a company director.

Key Dates